| |
|
|
|
Arcadia Bio  
|
|
3.45 0.4 (0.13%) |
01-22 16:00 |
|
Open: |
3.07 |
Pre close: |
3.05 |
Target:
|
4.17 
|
|
High: |
3.5691 |
Low: |
3.05 |
Resistance:
|
3.57
4.17
|
|
Volume: |
1,314,269 |
Market Cap: |
46M |
Support:
|
2.81
2.34
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.13
|
MACD |
MACD(12,26):
|
0.08 |
|
MA(20): |
2.75 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
3.00 |
Stochastic Oscillator |
%K(14,3):
|
80.70 |
|
MA(250): |
3.51  |
%D(3): |
77.60 |
|
Average Volume(K) |
3-Month: |
38543
|
52-Week |
High:
|
6.48 |
|
10-Days: |
71728 |
Low: |
2.30 |
|
RSI |
RSI(14):
|
73.00 |
Change(%): |
-28.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.123 |
Return on Equity (ttm) |
-159.7 |
Shares Out. (M) |
13.45 |
|
EPS Est. Current Year |
-0.360 |
Return on Assets (ttm) |
-39.1 |
Shares Float (M) |
9.88 |
|
EPS Est. Next Year |
-0.220 |
PEG Ratio |
0.00 |
% Held by Insiders |
12.19 |
|
EPS Est. Next Quarter |
-0.080 |
Qtrly Rev. Growth |
-19.9 |
% Held by Institutions |
11.16 |
|
Forward EPS |
-4.530 |
Gross Profit (p.s.) |
-0.506 |
Shares Short (K) |
97 |
|
Book Value (p.s.) |
1.040 |
EBITDA (p.s.) |
-1.622 |
P/E |
-1.63 |
|
Sales Per Share |
0.098 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.32 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-28.48 |
P/S |
35.15 |
|
Operating Margin |
-1687.05 |
Levered Free Cash Flow
(M) |
-19.10 |
P/CF |
-1.63 |
|
|
|
|
|
|
